
FDA advises nucleic acid tests to screen for hepatitis B virus.
Self-reported psychological well-being superior in patients with leukemia after a bone marrow transplant compared with peripheral blood transplants.
Some breast cancer tumors are not sensitive to Herceptin.
How specialty pharmacies can improve the treatment success of women receiving in-vitro fertilization.
Researchers examine whether cognitive impairment caused by chemotherapy drugs in breast cancer patients is a long-term issue.
Genes related to eye color may cause cancer of the eye.
Top news of the day from across the healthcare landscape.
Cancer genomics reveal genetic mutations that aid tumor growth in prostate cancer.
Treating cellular survival mechanism may prove to be a promising treatment approach for cancer.
Prescribed diabetes therapies may be leading to reduced kidney function.
Optimizing workflow can enhance the specialty pharmacy patient experience.
Test can identify multiple sclerosis from other neurological conditions.
The combination of emtricitabine/tenofovir alafenamide did not show a treatment benefit over comparator therapies.
Nanoparticle capsule to deliver experimental drug shows promise treating pancreatic cancer.
Top news of the day from across the health care landscape.
Etoposide may cause ovarian tissue damage that impacts the fertility of the unborn child.
Early treatment for HIV and tuberculosis found to improve outcomes.
Organ rejection is caused by donor dendritic cells being rapidly replaced by the recipient’s cells.
Hepatitis C testing is often skipped during baby boomer physician office visits.
Top news of the week in oncology, and cancer drug development.
Combination therapy may be viable for patients with moderate-to-severe psoriasis unresponsive to non-biologic treatments.
Breast cancer patients who expected significant side effects from adjuvant hormone therapy reported worse adverse events.
The impact of antiviral hepatitis C drugs in day-to-day life will be examined.
Newly found protein sheds light on insulin resistance and type 2 diabetes.
Researchers advance understanding of how breast cancer drugs work inside human cells.
Findings point to need to target only non-damaged HIV in the body.
Top news of the week from Specialty Pharmacy Times.
Top news of the day from across the health care landscape.
Microfluidic device may improve treatment of abnormal blood coagulation.